Bentham Science Logo

Track Your Manuscript:


Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 20, 10 Issues, 2020
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Volume 4 - Number 1

Melatonin Role in Experimental Arthritis

, 4(1): 1 - 10

Daniel P. Cardinali, Ana P. Garcia, Pilar Cano and Ana I. Esquifino


DOI: 10.2174/1568008043340071







HDL and Inflammation in Atherosclerosis

, 4(1): 51 - 57

Lukas E. Spieker, Frank Ruschitzka, Thomas F. Luscher and Georg Noll


DOI: 10.2174/1568005310404010051



The Paracrine Role Played by Interleukin-1α in the Testis

, 4(1): 67 - 74

K. Svechnikov, C. Petersen, T. Sultana, A. Wahlgren, C. Zetterstrom, E. Colon, C. Bornestaf and O. Soder


DOI: 10.2174/1568005310404010067






Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.
Scopus CiteScore Metrics: 1.79

Society Accreditations



Society Name: The official Journal of Associazione Medici Endocrinologi


Advertisement

Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog